Skip to main content
. 2021 May 11;11:9984. doi: 10.1038/s41598-021-88239-y

Figure 5.

Figure 5

Survival analysis by line of therapy. Kaplan–Meier curves for (top row) progression-free survival and (bottom row) overall survival in first-line patients (left) and second- and third-line patients (right), showing that the radiomic tumor phenotypes can further sub-stratify patients in the second or third line of treatment.